A Forgotten Foe Returns: The Diagnostic Odyssey of Kala‐Azar Masquerading as Myelodysplastic Syndrome in a Post‐Elimination Era

We report a diagnostically complex case of visceral leishmaniasis (Kala‐azar) in a 73‐year‐old male from a country where the disease was eliminated in 2023. The patient presented with a 2‐month history of low‐grade fever, fatigue, progressive skin hyperpigmentation over 2 years, and hepatosplenomegaly. Initial investigations revealed pancytopenia (hemoglobin 10.4 g/dL, white blood cells 3500/mm3, platelets 60,000/mm3), prompting a differential diagnosis of Kala‐azar versus myelodysplastic syndrome (MDS). The rapid diagnostic test (rK39) for Kala‐azar was positive, but bone marrow examination showed dysplastic changes, hypercellularity, decreased myeloid‐erythroid ratio, binucleate erythrocytes, and maturation arrest at the myelocyte stage without Leishmania donovani (LD) bodies, complicating the diagnosis. Financial constraints precluded fluorescence in situ hybridization (FISH) testing for MDS confirmation. Repeated peripheral blood film (PBF) and rK39 testing (qDetect Kala‐azar) on February 6, 2025, confirmed Kala‐azar, ruling out MDS as the primary pathology. The patient responded well to liposomal amphotericin B treatment (3 mg/kg/day according to WHO regimen). This case underscores the challenge of diagnosing Kala‐azar in post‐elimination settings, particularly when clinical and laboratory features overlap with hematological disorders like MDS. It highlights the critical need for persistent diagnostic evaluation, including repeated serological and hematological testing, to differentiate infectious causes from malignancies in patients with unexplained pancytopenia. Clinicians must remain vigilant for re‐emerging infectious diseases, even in regions where they are deemed eliminated, to ensure accurate diagnosis and prompt treatment, ultimately improving patient outcomes in resource‐limited settings.

• Publication year

  2025

• Venue

  Clinical Case Reports

• Publication date

  2025-11-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1002/ccr3.71402PMID 41221365PMCID 12597612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patient-centric care in myelodysplastic syndromes: A global systematic literature review and gap analysis.

  2024cited by this paper
• Bangladesh eliminates visceral leishmaniasis.

  2024cited by this paper
• Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management

  2023cited by this paper
• Assessment of Knowledge, Attitudes, and Practices toward Kala-azar in an Endemic District in Bangladesh: A Cross-Sectional Survey.

  2023cited by this paper
• Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis

  2021cited by this paper
• Early diagnosis of kala-azar in Bangladesh: Findings from a population based mixed methods research informing the post-elimination era.

  2021cited by this paper
• Aplastic Anemia

  2020cited by this paper
• Housing Characteristics and Leishmaniasis: A Systematic Review.

  2018cited by this paper
• Elimination of Kala-Azar from the Southeast Asia Region.

  2017cited by this paper
• Leishmaniasis and various immunotherapeutic approaches

  2016cited by this paper
• Recent developments and future prospects in the treatment of visceral leishmaniasis

  2016cited by this paper
• Global distribution maps of the leishmaniases

  2014cited by this paper
• Epidemiology of visceral leishmaniasis

  2014cited by this paper
• An etiological reappraisal of pancytopenia - largest series reported to date from a single tertiary care teaching hospital

  2013cited by this paper
• Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of Bangladesh

  2010cited by this paper
• In Search of an Ideal Test for Diagnosis and Prognosis of Kala-azar

  2010cited by this paper
• Phlebotomine sand flies and Leishmania parasites: friends or foes?

  2006cited by this paper
• Risk Factors for Kala-Azar in Bangladesh

  2005cited by this paper
• Visceral leishmaniasis masquerading as myelodysplasia

  2003cited by this paper
• Post-kala-azar dermal leishmaniasis.

  2003cited by this paper
• Laboratory Diagnosis of Visceral Leishmaniasis

  2002cited by this paper
• MANAGEMENT OF KALA AZAR - AN UPDATE.

  1996cited by this paper
• Laboratory diagnosis of visceral leishmaniasis.

  1996influential reference
• POST KALA‐AZAR DERMAL LEISHMANIASIS

  1972cited by this paper

• No citing papers are available for this paper.